Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Schizophrenia significantly shortens life expectancy by an estimated 15 years with excess mortality arising from multiple ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

Hikma Pharmaceuticals PLC HIK shares shed 1.94% to £18.20 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.14% to ...

Hikma Pharmaceuticals reiterated its full-year outlook on Thursday on the back of strong trading across the business.

General Anesthesia Drugs MarketThe global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate ...

FMI’s latest analysis underscores a remarkable surge in demand for pharmaceutical products within the Kingdom, with market value expected to exceed USD 10,113.1 million by 2024. This impressive growth ...

European stocks closed weak on Friday with investors reacting to corporate earnings announcements, and assessing the Bank of England ...

This page features the latest news about the Hikma Pharma ADR stock. U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.37% Investing.com – U.K. stocks were higher after ...